Methods
This is a single-center, retrospective review of LT patients who
received NMB antagonists intraoperatively between 01/01/2015 to
05/31/2018 at Mayo Clinic in Florida. The primary outcomes were
postoperative day (POD) 0-1 bleeding events and POD 0 values of aPTT and
INR.